T-Cell Maturation & Adaptive Immune Regulation
Thymosin Alpha-1 (Tα1) — Thymic Immunomodulatory Peptide
Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide originally isolated from thymosin fraction 5 of bovine thymic tissue by Allan Goldstein in the 1970s. It is the N-terminal fragment of prothymosin alpha, a nuclear protein involved in chromatin remodeling, and serves as a potent immunomodulatory agent that promotes T-cell maturation, enhances innate immune responses, and modulates the balance between pro- and anti-inflammatory cytokines.
Tα1 is approved in over 35 countries (marketed as Zadaxin®) for the treatment of chronic hepatitis B, chronic hepatitis C, and as an adjuvant for influenza vaccination in immunocompromised patients. This extensive clinical history provides a robust human safety and efficacy dataset that distinguishes Tα1 from most research peptides.
Thymosin Alpha-1 is a 28-amino-acid peptide with an N-terminal acetyl group (Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH). The N-terminal acetylation is required for full biological activity. The molecular weight is 3,108.4 Daltons.
The peptide is highly acidic (net charge -6 at physiological pH) due to its high content of aspartate and glutamate residues, a property that distinguishes it from most other immunomodulatory peptides and may influence its receptor interactions and biodistribution.
Thymosin Alpha-1 exerts its immunomodulatory effects through multiple mechanisms. Its primary activity involves promotion of T-cell maturation and differentiation: Tα1 stimulates the expression of T-cell surface markers (CD3, CD4, CD8) on immature thymocytes and promotes the differentiation of naive T cells toward Th1 effector phenotypes, enhancing cell-mediated immunity.
Tα1 also activates toll-like receptor 9 (TLR9) signaling in dendritic cells and macrophages, stimulating the production of type I interferons (IFN-α/β) and pro-inflammatory cytokines (IL-12, TNF-α) that are critical for antiviral and antitumor immunity. Additionally, Tα1 upregulates MHC class I and II expression on antigen-presenting cells, enhancing antigen presentation to T cells.
In the context of chronic infection, Tα1 reverses T-cell exhaustion — the progressive loss of T-cell function that occurs during persistent antigen stimulation — by restoring effector T-cell responses.
Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide naturally produced by the thymus gland — the organ responsible for training and maturing T-cells, the immune system's most sophisticated defenders. It's been approved as a drug (Zadaxin®) in over 35 countries for hepatitis B, hepatitis C, and as an immune adjuvant for cancer treatment and vaccines. It's one of the most clinically validated immunomodulatory peptides in existence.
Thymosin Alpha-1 works by activating dendritic cells and macrophages (the immune system's commanders), stimulating T-cell maturation and differentiation, and upregulating toll-like receptor (TLR) signaling — the innate immune system's pattern recognition machinery. The net effect is a more robust, better-coordinated immune response. In clinical studies, it has improved outcomes in chronic viral infections, sepsis, and as a vaccine adjuvant (it enhances the immune response to vaccines).
Immune dysfunction — whether from aging (immunosenescence), chronic infection, or immunosuppressive therapy — is a major driver of morbidity and mortality. Thymosin Alpha-1's approval in 35+ countries for viral hepatitis and its use as a vaccine adjuvant gives it a clinical validation profile that few research peptides can match. Its mechanism of restoring T-cell competence is particularly relevant to aging research, as thymic function declines significantly with age.
Thymosin Alpha-1 is one of the most clinically validated immunomodulatory peptides in this catalog, with drug approval in over 35 countries. Its thymic origin, T-cell modulating mechanism, and clinical track record in viral infections and cancer adjuvant therapy make it a cornerstone of immune research. The research-grade lyophilized powder supplied by Purgo Labs is for laboratory use only.
Stimulates T-cell surface marker expression and promotes Th1 effector differentiation, enhancing cell-mediated immunity against pathogens and tumors.
Activates TLR9 in dendritic cells and macrophages, stimulating IFN-α/β and IL-12 production critical for antiviral and antitumor responses.
Increases MHC class I and II expression on antigen-presenting cells, enhancing antigen presentation efficiency to CD8+ and CD4+ T cells.
Restores effector T-cell function in chronic infection settings by reversing exhaustion markers (PD-1, TIM-3) and restoring cytokine production.
1 cited study — model, sample size, outcome, and effect size from published literature.
| Study | Model | Sample | Outcome | Effect Size | Level |
|---|---|---|---|---|---|
Goldstein AL, et al. (2012) Thymosin α1: chemistry and biological properties PubMed | Human — multiple clinical trials | Multiple trials (n=50–200) | Enhanced T-cell maturation; improved immune response in cancer and viral infections | Significant improvement in T-cell counts and immune markers vs. control | RCT |
Immune Research
≥99% purity · Third-party tested
Use code Health for 15% off
Fast FedEx shipping · 60-day guarantee
| Peptide Class | Thymic immunomodulatory peptide (28 amino acids) |
| Molecular Weight | 3,108.4 Da |
| Regulatory Status | Approved in 35+ countries (Zadaxin®) |
| Net Charge | -6 at physiological pH (highly acidic) |
| Available Sizes | 5mg vials |
| Form | Lyophilized powder |
| Purity | ≥99% (third-party tested) |
View full legal status guide →
Purgo Labs offers Thymosin Alpha-1 with ≥99% purity, third-party certificates of analysis, and fast FedEx shipping. This is an affiliate link — we may earn a commission at no cost to you.
Purchase Thymosin Alpha-1 at Purgo LabsMedical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.
